# LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies

> **NCT04657965** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Zhejiang University** · enrollment: 144 (estimated)

## Conditions studied

- Infectious Diseases
- Hematological Malignancies

## Interventions

- **DRUG:** LMP1 CAR T-cells

## Key facts

- **NCT ID:** NCT04657965
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2021-01-15
- **Primary completion:** 2024-01-15
- **Final completion:** 2027-01-15
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2020-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04657965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04657965, "LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04657965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*